Established Pharmaceuticals — Net Sales
Abbott Established Pharmaceuticals — Net Sales increased by 3.2% to $1.43B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.2%, from $1.26B to $1.43B. Over 4 years (FY 2021 to FY 2025), Established Pharmaceuticals — Net Sales shows an upward trend with a 4.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests strong demand or successful expansion in international markets, while a decrease may indicate competitive pressure or patent expirations.
Detailed definition
This metric represents the total revenue generated from the sale of branded generic pharmaceutical products within the e...
Peer comparison
Comparable to revenue metrics for generic or mature drug divisions at other global pharmaceutical companies.
abt_segment_established_pharmaceuticals_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 1.2B | 1.3B | 1.2B | 1.1B | 1.2B | 1.3B | 1.2B | 1.2B | 1.3B | 1.4B | 1.2B | 1.2B | 1.3B | 1.4B | 1.3B | 1.3B | 1.4B | 1.5B | 1.4B | 1.4B |
| QoQ Change | — | +7.2% | -4.9% | -4.7% | +6.6% | +8.4% | -8.3% | -2.2% | +8.2% | +6.3% | -10.7% | +0.3% | +5.5% | +8.7% | -9.8% | -0.6% | +9.8% | +9.3% | -8.5% | +3.2% |
| YoY Change | — | — | — | — | +3.6% | +4.8% | +1.1% | +3.7% | +5.2% | +3.2% | +0.5% | +3.1% | +0.5% | +2.8% | +3.8% | +2.8% | +6.9% | +7.5% | +9.0% | +13.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Abbott's established pharmaceuticals — net sales?
- Abbott (ABT) reported established pharmaceuticals — net sales of $1.43B in Q1 2026.
- How has Abbott's established pharmaceuticals — net sales changed year-over-year?
- Abbott's established pharmaceuticals — net sales increased by 13.2% year-over-year, from $1.26B to $1.43B.
- What is the long-term trend for Abbott's established pharmaceuticals — net sales?
- Over 4 years (2021 to 2025), Abbott's established pharmaceuticals — net sales has grown at a 4.1% compound annual growth rate (CAGR), from $4.72B to $5.54B.
- What does established pharmaceuticals — net sales mean?
- Total revenue earned from the sale of established pharmaceutical products.